Anti-PD-1 +/- RT for MSI-H Solid Tumors

NCT04001101 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI has decided to withdraw the study

Conditions

Microsatellite Instability High
Mismatch Repair Deficiency
Colorectal Cancer

Interventions

COMBINATION_PRODUCT: RT and Anti-PD-1
DRUG: Anti-PD-1

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]